| Application no. and date | 01906554.9 (espacenet) (Federated) (European Patent Register), 20010212 | | Patent/reg. no. and date | DK/EP 1259513, 20030910 | | Publication date | 20021127 | | Priority no. and date | US 184964 P, 20000225 | | EP pub. no. and date |
EP 1259513 20021127 | | Effective date | | | Applicant/owner | ELI LILLY AND COMPANY, Lilly Corporate Center,
Drop Code 1104
Indianapolis, IN 46285, US | | Applicant ref. no. | P200301322 EP DK | | Inventor | CHELIUS, Erik, Christopher, Barna, Innishannon
County Cork, IE,
SNOREK, Sharon, Van den Berghe, 4616 Doe Path Lane
Lafayette, IN 47905, US,
REUTZEL-EDENS, Susan, Marie, 7519 Fox Hollow Ridge
Zionsville ,IN 46077, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/519, A61P 35/00, C07D 487/04 | | Title | Ny krystallinsk form af N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutaminsyre og fremgangsmåder til dets fremstilling | | Int. application no. | US2001001229 | | Int. publication no. | WO2001062760 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
